Abstract
To Study the Role of Bosentan in Patients with Irreversible Obstructive Pulmonary Disease Having Mild to Moderate Pulmonary Arterial Hypertension
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have